Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | Psma5 | Rat | (1->4)-beta-D-glucan | multiple interactions | ISO | Psma5 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of PSMA5 mRNA | CTD | PMID:36331819 | Psma5 | Rat | 1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane | affects expression | EXP | | 6480464 | o,p'-DDT affects the expression of PSMA5 mRNA | CTD | PMID:17984292 | Psma5 | Rat | 1,2-dimethylhydrazine | multiple interactions | ISO | Psma5 (Mus musculus) | 6480464 | [1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of PSMA5 mRNA | CTD | PMID:22206623 | Psma5 | Rat | 1,2-dimethylhydrazine | decreases expression | ISO | Psma5 (Mus musculus) | 6480464 | 1,2-Dimethylhydrazine results in decreased expression of PSMA5 mRNA | CTD | PMID:22206623 | Psma5 | Rat | 1,3-dinitrobenzene | increases expression | EXP | | 6480464 | 3-dinitrobenzene results in increased expression of PSMA5 mRNA | CTD | PMID:24140754 | Psma5 | Rat | 1-chloro-2,4-dinitrobenzene | decreases expression | ISO | PSMA5 (Homo sapiens) | 6480464 | Dinitrochlorobenzene results in decreased expression of PSMA5 mRNA | CTD | PMID:17374397 | Psma5 | Rat | 1-chloro-2,4-dinitrobenzene | affects binding | ISO | PSMA5 (Homo sapiens) | 6480464 | Dinitrochlorobenzene binds to PSMA5 protein | CTD | PMID:32991956 | Psma5 | Rat | 17alpha-ethynylestradiol | multiple interactions | ISO | Psma5 (Mus musculus) | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of PSMA5 mRNA | CTD | PMID:17942748 | Psma5 | Rat | 17alpha-ethynylestradiol | increases expression | ISO | Psma5 (Mus musculus) | 6480464 | Ethinyl Estradiol results in increased expression of PSMA5 mRNA | CTD | PMID:16174780|PMID:17942748|PMID:19400957 | Psma5 | Rat | 17alpha-ethynylestradiol | increases expression | EXP | | 6480464 | Ethinyl Estradiol results in increased expression of PSMA5 mRNA | CTD | PMID:16174780|PMID:19400957 | Psma5 | Rat | 17beta-estradiol | increases expression | ISO | Psma5 (Mus musculus) | 6480464 | Estradiol results in increased expression of PSMA5 mRNA | CTD | PMID:39298647 | Psma5 | Rat | 1H-pyrazole | increases expression | ISO | Psma5 (Mus musculus) | 6480464 | pyrazole results in increased expression of PSMA5 mRNA | CTD | PMID:17945193 | Psma5 | Rat | 2,2',4,4'-Tetrabromodiphenyl ether | affects expression | ISO | Psma5 (Mus musculus) | 6480464 | 2,2',4,4'-tetrabromodiphenyl ether affects the expression of PSMA5 mRNA | CTD | PMID:30294300 | Psma5 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | Psma5 (Mus musculus) | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of PSMA5 mRNA | CTD | PMID:17942748 | Psma5 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Psma5 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of PSMA5 mRNA | CTD | PMID:21570461 | Psma5 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of PSMA5 mRNA | CTD | PMID:15358164 | Psma5 | Rat | 2,5-hexanedione | decreases expression | EXP | | 6480464 | 2,5-hexanedione results in decreased expression of PSMA5 protein | CTD | PMID:15928459 | Psma5 | Rat | 2,6-dimethoxyphenol | multiple interactions | ISO | PSMA5 (Homo sapiens) | 6480464 | [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of and affects the more ... | CTD | PMID:38598786 | Psma5 | Rat | 2-amino-14,16-dimethyloctadecan-3-ol | decreases expression | ISO | PSMA5 (Homo sapiens) | 6480464 | 2-amino-14,16-dimethyloctadecan-3-ol results in decreased expression of PSMA5 protein | CTD | PMID:32044396 | Psma5 | Rat | 2-hydroxypropanoic acid | decreases expression | ISO | PSMA5 (Homo sapiens) | 6480464 | Lactic Acid results in decreased expression of PSMA5 mRNA | CTD | PMID:30851411 | Psma5 | Rat | 2-nitrofluorene | increases expression | EXP | | 6480464 | 2-nitrofluorene results in increased expression of PSMA5 mRNA | CTD | PMID:15890375 | Psma5 | Rat | 3H-1,2-dithiole-3-thione | increases expression | ISO | Psma5 (Mus musculus) | 6480464 | 1,2-dithiol-3-thione results in increased expression of PSMA5 mRNA | CTD | PMID:15375163 | Psma5 | Rat | 4,4'-diaminodiphenylmethane | affects expression | ISO | Psma5 (Mus musculus) | 6480464 | 4,4'-diaminodiphenylmethane affects the expression of PSMA5 mRNA | CTD | PMID:18648102 | Psma5 | Rat | 4,4'-sulfonyldiphenol | increases expression | ISO | Psma5 (Mus musculus) | 6480464 | bisphenol S results in increased expression of PSMA5 mRNA | CTD | PMID:39298647 | Psma5 | Rat | 4-(ethoxymethylene)-2-phenyloxazol-5-one | decreases expression | ISO | PSMA5 (Homo sapiens) | 6480464 | Oxazolone results in decreased expression of PSMA5 mRNA | CTD | PMID:17374397 | Psma5 | Rat | 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one | decreases expression | EXP | | 6480464 | 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in decreased expression of PSMA5 mRNA | CTD | PMID:15890375 | Psma5 | Rat | acrolein | multiple interactions | ISO | PSMA5 (Homo sapiens) | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of more ... | CTD | PMID:32699268|PMID:32845096 | Psma5 | Rat | aflatoxin B1 | increases expression | EXP | | 6480464 | Aflatoxin B1 results in increased expression of PSMA5 mRNA | CTD | PMID:15890375 | Psma5 | Rat | aflatoxin B1 | decreases methylation | ISO | PSMA5 (Homo sapiens) | 6480464 | Aflatoxin B1 results in decreased methylation of PSMA5 gene | CTD | PMID:27153756 | Psma5 | Rat | alpha-pinene | multiple interactions | ISO | PSMA5 (Homo sapiens) | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of more ... | CTD | PMID:32699268 | Psma5 | Rat | ammonium chloride | affects expression | EXP | | 6480464 | Ammonium Chloride affects the expression of PSMA5 mRNA | CTD | PMID:16483693 | Psma5 | Rat | antirheumatic drug | decreases expression | ISO | PSMA5 (Homo sapiens) | 6480464 | Antirheumatic Agents results in decreased expression of PSMA5 mRNA | CTD | PMID:24449571 | Psma5 | Rat | aristolochic acid A | increases expression | ISO | PSMA5 (Homo sapiens) | 6480464 | aristolochic acid I results in increased expression of PSMA5 protein | CTD | PMID:33212167 | Psma5 | Rat | arsenite(3-) | multiple interactions | ISO | PSMA5 (Homo sapiens) | 6480464 | arsenite promotes the reaction [G3BP1 protein binds to PSMA5 mRNA] | CTD | PMID:32406909 | Psma5 | Rat | arsenous acid | decreases expression | ISO | PSMA5 (Homo sapiens) | 6480464 | Arsenic Trioxide results in decreased expression of PSMA5 protein | CTD | PMID:19364129 | Psma5 | Rat | atrazine | decreases expression | ISO | PSMA5 (Homo sapiens) | 6480464 | Atrazine results in decreased expression of PSMA5 mRNA | CTD | PMID:22378314 | Psma5 | Rat | beauvericin | multiple interactions | ISO | PSMA5 (Homo sapiens) | 6480464 | [beauvericin co-treated with enniatins] results in increased expression of PSMA5 protein | CTD | PMID:32407736 | Psma5 | Rat | benzo[a]pyrene | increases expression | ISO | Psma5 (Mus musculus) | 6480464 | Benzo(a)pyrene results in increased expression of PSMA5 mRNA | CTD | PMID:19770486|PMID:21715664|PMID:22228805 | Psma5 | Rat | beta-lapachone | increases expression | ISO | PSMA5 (Homo sapiens) | 6480464 | beta-lapachone results in increased expression of PSMA5 mRNA | CTD | PMID:38218311 | Psma5 | Rat | beta-naphthoflavone | increases expression | ISO | PSMA5 (Homo sapiens) | 6480464 | beta-Naphthoflavone results in increased expression of PSMA5 protein | CTD | PMID:39638853 | Psma5 | Rat | bis(2-ethylhexyl) phthalate | increases expression | EXP | | 6480464 | Diethylhexyl Phthalate results in increased expression of PSMA5 mRNA | CTD | PMID:21318169 | Psma5 | Rat | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of PSMA5 mRNA | CTD | PMID:25181051 | Psma5 | Rat | bisphenol A | decreases expression | ISO | PSMA5 (Homo sapiens) | 6480464 | bisphenol A results in decreased expression of PSMA5 mRNA; bisphenol A results in decreased expression more ... | CTD | PMID:29275510|PMID:34186270 | Psma5 | Rat | bisphenol AF | increases expression | ISO | PSMA5 (Homo sapiens) | 6480464 | bisphenol AF results in increased expression of PSMA5 protein | CTD | PMID:34186270 | Psma5 | Rat | Bisphenol B | increases expression | ISO | PSMA5 (Homo sapiens) | 6480464 | bisphenol B results in increased expression of PSMA5 protein | CTD | PMID:34186270 | Psma5 | Rat | bisphenol F | increases expression | ISO | Psma5 (Mus musculus) | 6480464 | bisphenol F results in increased expression of PSMA5 mRNA | CTD | PMID:38685157 | Psma5 | Rat | bisphenol F | increases expression | ISO | PSMA5 (Homo sapiens) | 6480464 | bisphenol F results in increased expression of PSMA5 protein | CTD | PMID:34186270 | Psma5 | Rat | cadmium atom | multiple interactions | ISO | Psma5 (Mus musculus) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PSMA5 more ... | CTD | PMID:37236586 | Psma5 | Rat | cadmium dichloride | affects localization | ISO | PSMA5 (Homo sapiens) | 6480464 | Cadmium Chloride affects the localization of PSMA5 protein | CTD | PMID:18261755 | Psma5 | Rat | cadmium dichloride | multiple interactions | ISO | Psma5 (Mus musculus) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PSMA5 more ... | CTD | PMID:37236586 | Psma5 | Rat | caffeine | increases expression | ISO | PSMA5 (Homo sapiens) | 6480464 | Caffeine results in increased expression of PSMA5 protein | CTD | PMID:31195006 | Psma5 | Rat | caffeine | decreases phosphorylation | ISO | PSMA5 (Homo sapiens) | 6480464 | Caffeine results in decreased phosphorylation of PSMA5 protein | CTD | PMID:35688186 | Psma5 | Rat | carbon nanotube | increases expression | ISO | Psma5 (Mus musculus) | 6480464 | Nanotubes, Carbon analog results in increased expression of PSMA5 mRNA; Nanotubes, Carbon results in increased more ... | CTD | PMID:25554681 | Psma5 | Rat | chloropicrin | increases expression | ISO | PSMA5 (Homo sapiens) | 6480464 | chloropicrin results in increased expression of PSMA5 mRNA | CTD | PMID:26352163 | Psma5 | Rat | clobetasol | increases expression | ISO | Psma5 (Mus musculus) | 6480464 | Clobetasol results in increased expression of PSMA5 mRNA | CTD | PMID:27462272 | Psma5 | Rat | clofibrate | increases expression | ISO | Psma5 (Mus musculus) | 6480464 | Clofibrate results in increased expression of PSMA5 mRNA | CTD | PMID:17585979 | Psma5 | Rat | clofibrate | increases expression | EXP | | 6480464 | Clofibrate results in increased expression of PSMA5 mRNA | CTD | PMID:21318169 | Psma5 | Rat | coumarin | decreases phosphorylation | ISO | PSMA5 (Homo sapiens) | 6480464 | coumarin results in decreased phosphorylation of PSMA5 protein | CTD | PMID:35688186 | Psma5 | Rat | cyclophosphamide | increases expression | ISO | PSMA5 (Homo sapiens) | 6480464 | Cyclophosphamide results in increased expression of PSMA5 protein | CTD | PMID:17475930 | Psma5 | Rat | cyclosporin A | increases expression | ISO | PSMA5 (Homo sapiens) | 6480464 | Cyclosporine results in increased expression of PSMA5 mRNA | CTD | PMID:20106945 | Psma5 | Rat | cyproconazole | increases expression | ISO | Psma5 (Mus musculus) | 6480464 | cyproconazole results in increased expression of PSMA5 mRNA | CTD | PMID:22334560 | Psma5 | Rat | diarsenic trioxide | decreases expression | ISO | PSMA5 (Homo sapiens) | 6480464 | Arsenic Trioxide results in decreased expression of PSMA5 protein | CTD | PMID:19364129 | Psma5 | Rat | dibenzo[a,l]pyrene | decreases expression | ISO | Psma5 (Mus musculus) | 6480464 | dibenzo(a,l)pyrene results in decreased expression of PSMA5 mRNA | CTD | PMID:25908611 | Psma5 | Rat | Dibutyl phosphate | affects expression | ISO | PSMA5 (Homo sapiens) | 6480464 | di-n-butylphosphoric acid affects the expression of PSMA5 mRNA | CTD | PMID:37042841 | Psma5 | Rat | dicrotophos | decreases expression | ISO | PSMA5 (Homo sapiens) | 6480464 | dicrotophos results in decreased expression of PSMA5 mRNA | CTD | PMID:28302478 | Psma5 | Rat | diethylstilbestrol | increases expression | EXP | | 6480464 | Diethylstilbestrol results in increased expression of PSMA5 mRNA | CTD | PMID:15890375 | Psma5 | Rat | diuron | decreases expression | ISO | PSMA5 (Homo sapiens) | 6480464 | Diuron results in decreased expression of PSMA5 mRNA | CTD | PMID:35967413 | Psma5 | Rat | dorsomorphin | multiple interactions | ISO | PSMA5 (Homo sapiens) | 6480464 | [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased more ... | CTD | PMID:27188386 | Psma5 | Rat | doxorubicin | increases metabolic processing | ISO | PSMA5 (Homo sapiens) | 6480464 | Doxorubicin results in increased metabolism of PSMA5 protein | CTD | PMID:17346995 | Psma5 | Rat | enniatin | multiple interactions | ISO | PSMA5 (Homo sapiens) | 6480464 | [beauvericin co-treated with enniatins] results in increased expression of PSMA5 protein | CTD | PMID:32407736 | Psma5 | Rat | epoxiconazole | increases expression | ISO | Psma5 (Mus musculus) | 6480464 | epoxiconazole results in increased expression of PSMA5 mRNA | CTD | PMID:22334560|PMID:35436446 | Psma5 | Rat | ethanol | increases expression | ISO | Psma5 (Mus musculus) | 6480464 | Ethanol results in increased expression of PSMA5 mRNA | CTD | PMID:30319688 | Psma5 | Rat | finasteride | increases expression | EXP | | 6480464 | Finasteride results in increased expression of PSMA5 mRNA | CTD | PMID:24136188 | Psma5 | Rat | fipronil | decreases expression | EXP | | 6480464 | fipronil results in decreased expression of PSMA5 mRNA | CTD | PMID:34044035 | Psma5 | Rat | flavonoids | increases expression | EXP | | 6480464 | Flavonoids results in increased expression of PSMA5 mRNA | CTD | PMID:18035473 | Psma5 | Rat | flutamide | increases expression | EXP | | 6480464 | Flutamide results in increased expression of PSMA5 mRNA | CTD | PMID:24136188 | Psma5 | Rat | folic acid | multiple interactions | ISO | Psma5 (Mus musculus) | 6480464 | [1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of PSMA5 mRNA | CTD | PMID:22206623 | Psma5 | Rat | FR900359 | decreases phosphorylation | ISO | PSMA5 (Homo sapiens) | 6480464 | FR900359 results in decreased phosphorylation of PSMA5 protein | CTD | PMID:37730182 | Psma5 | Rat | furfural | multiple interactions | ISO | PSMA5 (Homo sapiens) | 6480464 | [Sodium Chloride co-treated with Furaldehyde] results in decreased expression of and affects the localization of more ... | CTD | PMID:38598786 | Psma5 | Rat | gentamycin | increases expression | EXP | | 6480464 | Gentamicins results in increased expression of PSMA5 mRNA | CTD | PMID:22061828 | Psma5 | Rat | hydrogen peroxide | multiple interactions | ISO | Psma5 (Mus musculus) | 6480464 | [Hydrogen Peroxide co-treated with N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride] results in increased phosphorylation of PSMA5 protein | CTD | PMID:31494107 | Psma5 | Rat | inulin | multiple interactions | ISO | Psma5 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of PSMA5 mRNA | CTD | PMID:36331819 | Psma5 | Rat | isotretinoin | decreases expression | ISO | PSMA5 (Homo sapiens) | 6480464 | Isotretinoin results in decreased expression of PSMA5 mRNA | CTD | PMID:20436886 | Psma5 | Rat | ivermectin | decreases expression | ISO | PSMA5 (Homo sapiens) | 6480464 | Ivermectin results in decreased expression of PSMA5 protein | CTD | PMID:32959892 | Psma5 | Rat | lead(0) | affects splicing | ISO | PSMA5 (Homo sapiens) | 6480464 | Lead affects the splicing of PSMA5 mRNA | CTD | PMID:28903495 | Psma5 | Rat | leflunomide | increases expression | EXP | | 6480464 | leflunomide results in increased expression of PSMA5 mRNA | CTD | PMID:24136188 | Psma5 | Rat | methamphetamine | decreases expression | EXP | | 6480464 | Methamphetamine results in decreased expression of PSMA5 mRNA | CTD | PMID:15644446 | Psma5 | Rat | methapyrilene | increases expression | EXP | | 6480464 | Methapyrilene results in increased expression of PSMA5 mRNA | CTD | PMID:15890375 | Psma5 | Rat | miconazole | increases expression | ISO | Psma5 (Mus musculus) | 6480464 | Miconazole results in increased expression of PSMA5 mRNA | CTD | PMID:27462272 | Psma5 | Rat | morphine | increases expression | EXP | | 6480464 | Morphine results in increased expression of PSMA5 protein | CTD | PMID:23056601 | Psma5 | Rat | N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal | increases expression | ISO | Psma5 (Mus musculus) | 6480464 | benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of PSMA5 mRNA | CTD | PMID:15525353 | Psma5 | Rat | N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal | increases expression | ISO | PSMA5 (Homo sapiens) | 6480464 | benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of PSMA5 mRNA | CTD | PMID:31806706 | Psma5 | Rat | N-methyl-4-phenylpyridinium | decreases expression | ISO | Psma5 (Mus musculus) | 6480464 | 1-Methyl-4-phenylpyridinium results in decreased expression of PSMA5 protein | CTD | PMID:26558463 | Psma5 | Rat | N-nitrosodimethylamine | increases expression | EXP | | 6480464 | Dimethylnitrosamine results in increased expression of PSMA5 mRNA | CTD | PMID:15890375 | Psma5 | Rat | nefazodone | increases expression | EXP | | 6480464 | nefazodone results in increased expression of PSMA5 mRNA | CTD | PMID:24136188 | Psma5 | Rat | nickel atom | decreases expression | ISO | PSMA5 (Homo sapiens) | 6480464 | Nickel results in decreased expression of PSMA5 mRNA | CTD | PMID:23195993 | Psma5 | Rat | nickel sulfate | decreases expression | ISO | PSMA5 (Homo sapiens) | 6480464 | nickel sulfate results in decreased expression of PSMA5 mRNA | CTD | PMID:17374397 | Psma5 | Rat | nimesulide | increases expression | EXP | | 6480464 | nimesulide results in increased expression of PSMA5 mRNA | CTD | PMID:24136188 | Psma5 | Rat | nobiletin | multiple interactions | ISO | PSMA5 (Homo sapiens) | 6480464 | nobiletin inhibits the reaction [sodium arsenate results in decreased expression of PSMA5 protein] | CTD | PMID:38348393 | Psma5 | Rat | ozone | multiple interactions | ISO | PSMA5 (Homo sapiens) | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of more ... | CTD | PMID:32699268|PMID:32845096 | Psma5 | Rat | p-chloromercuribenzoic acid | increases expression | ISO | PSMA5 (Homo sapiens) | 6480464 | p-Chloromercuribenzoic Acid results in increased expression of PSMA5 mRNA | CTD | PMID:26272509 | Psma5 | Rat | p-chloromercuribenzoic acid | multiple interactions | ISO | PSMA5 (Homo sapiens) | 6480464 | [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased more ... | CTD | PMID:27188386 | Psma5 | Rat | p-menthan-3-ol | increases expression | ISO | PSMA5 (Homo sapiens) | 6480464 | Menthol results in increased expression of PSMA5 protein | CTD | PMID:26760959 | Psma5 | Rat | paracetamol | affects expression | ISO | Psma5 (Mus musculus) | 6480464 | Acetaminophen affects the expression of PSMA5 mRNA | CTD | PMID:17562736 | Psma5 | Rat | paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of PSMA5 mRNA | CTD | PMID:33387578 | Psma5 | Rat | paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of PSMA5 mRNA; Acetaminophen results in increased expression of PSMA5 more ... | CTD | PMID:15800402 | Psma5 | Rat | patulin | multiple interactions | ISO | Psma5 (Mus musculus) | 6480464 | NFE2L1 protein affects the reaction [Patulin results in increased expression of PSMA5 mRNA] | CTD | PMID:35367319 | Psma5 | Rat | patulin | increases expression | ISO | Psma5 (Mus musculus) | 6480464 | Patulin results in increased expression of PSMA5 mRNA | CTD | PMID:35367319 | Psma5 | Rat | pentachlorophenol | increases expression | ISO | Psma5 (Mus musculus) | 6480464 | Pentachlorophenol results in increased expression of PSMA5 mRNA | CTD | PMID:23892564 | Psma5 | Rat | perfluorooctane-1-sulfonic acid | affects expression | ISO | Psma5 (Mus musculus) | 6480464 | perfluorooctane sulfonic acid affects the expression of PSMA5 mRNA | CTD | PMID:19429403 | Psma5 | Rat | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | Psma5 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of PSMA5 mRNA; [perfluorooctane sulfonic more ... | CTD | PMID:36331819 | Psma5 | Rat | perfluorooctane-1-sulfonic acid | increases expression | ISO | Psma5 (Mus musculus) | 6480464 | perfluorooctane sulfonic acid results in increased expression of PSMA5 mRNA | CTD | PMID:20936131 | Psma5 | Rat | perfluorooctanoic acid | affects expression | ISO | Psma5 (Mus musculus) | 6480464 | perfluorooctanoic acid affects the expression of PSMA5 mRNA | CTD | PMID:19429403 | Psma5 | Rat | perfluorooctanoic acid | increases expression | ISO | Psma5 (Mus musculus) | 6480464 | perfluorooctanoic acid results in increased expression of PSMA5 mRNA | CTD | PMID:18467677|PMID:21318169 | Psma5 | Rat | perfluorooctanoic acid | multiple interactions | ISO | Psma5 (Mus musculus) | 6480464 | PPARA protein affects the reaction [perfluorooctanoic acid results in increased expression of PSMA5 mRNA]; PPARA more ... | CTD | PMID:18467677|PMID:21318169 | Psma5 | Rat | phenobarbital | increases expression | EXP | | 6480464 | Phenobarbital results in increased expression of PSMA5 mRNA | CTD | PMID:19162173|PMID:21318169 | Psma5 | Rat | piperonyl butoxide | increases expression | EXP | | 6480464 | Piperonyl Butoxide results in increased expression of PSMA5 mRNA | CTD | PMID:15890375|PMID:22484513 | Psma5 | Rat | pirinixic acid | multiple interactions | ISO | Psma5 (Mus musculus) | 6480464 | PPARA protein affects the reaction [pirinixic acid results in increased expression of PSMA5 mRNA]; PPARA more ... | CTD | PMID:18467677|PMID:21318169 | Psma5 | Rat | pirinixic acid | increases expression | ISO | Psma5 (Mus musculus) | 6480464 | pirinixic acid results in increased expression of PSMA5 mRNA | CTD | PMID:15375163|PMID:18301758|PMID:18467677|PMID:21318169|PMID:23811191 | Psma5 | Rat | pirinixic acid | increases expression | EXP | | 6480464 | pirinixic acid results in increased expression of PSMA5 mRNA | CTD | PMID:15890375 | Psma5 | Rat | pregnenolone 16alpha-carbonitrile | increases expression | EXP | | 6480464 | Pregnenolone Carbonitrile results in increased expression of PSMA5 mRNA | CTD | PMID:19162173|PMID:21318169 | Psma5 | Rat | propiconazole | increases expression | ISO | Psma5 (Mus musculus) | 6480464 | propiconazole results in increased expression of PSMA5 mRNA | CTD | PMID:22334560 | Psma5 | Rat | rac-lactic acid | decreases expression | ISO | PSMA5 (Homo sapiens) | 6480464 | Lactic Acid results in decreased expression of PSMA5 mRNA | CTD | PMID:30851411 | Psma5 | Rat | resveratrol | increases expression | ISO | Psma5 (Mus musculus) | 6480464 | resveratrol results in increased expression of PSMA5 protein | CTD | PMID:25505154 | Psma5 | Rat | Salinomycin | decreases expression | ISO | PSMA5 (Homo sapiens) | 6480464 | salinomycin results in decreased expression of PSMA5 mRNA | CTD | PMID:19682730 | Psma5 | Rat | SB 431542 | multiple interactions | ISO | PSMA5 (Homo sapiens) | 6480464 | [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased more ... | CTD | PMID:27188386 | Psma5 | Rat | sodium arsenate | multiple interactions | ISO | PSMA5 (Homo sapiens) | 6480464 | nobiletin inhibits the reaction [sodium arsenate results in decreased expression of PSMA5 protein] | CTD | PMID:38348393 | Psma5 | Rat | sodium arsenate | decreases expression | ISO | PSMA5 (Homo sapiens) | 6480464 | sodium arsenate results in decreased expression of PSMA5 protein | CTD | PMID:38348393 | Psma5 | Rat | sodium arsenite | decreases expression | ISO | Psma5 (Mus musculus) | 6480464 | sodium arsenite results in decreased expression of PSMA5 mRNA | CTD | PMID:36209798 | Psma5 | Rat | sodium arsenite | decreases expression | ISO | PSMA5 (Homo sapiens) | 6480464 | sodium arsenite results in decreased expression of PSMA5 mRNA | CTD | PMID:39719251 | Psma5 | Rat | sodium chloride | multiple interactions | ISO | PSMA5 (Homo sapiens) | 6480464 | [Sodium Chloride co-treated with Furaldehyde] results in decreased expression of and affects the localization of more ... | CTD | PMID:38598786 | Psma5 | Rat | sulindac | decreases expression | EXP | | 6480464 | Sulindac results in decreased expression of PSMA5 mRNA | CTD | PMID:24136188 | Psma5 | Rat | tamoxifen | increases expression | ISO | Psma5 (Mus musculus) | 6480464 | Tamoxifen results in increased expression of PSMA5 mRNA | CTD | PMID:19400957 | Psma5 | Rat | tamoxifen | increases expression | EXP | | 6480464 | Tamoxifen results in increased expression of PSMA5 mRNA | CTD | PMID:19400957 | Psma5 | Rat | titanium dioxide | decreases methylation | ISO | Psma5 (Mus musculus) | 6480464 | titanium dioxide results in decreased methylation of PSMA5 gene; titanium dioxide results in decreased methylation more ... | CTD | PMID:35295148 | Psma5 | Rat | trovafloxacin | multiple interactions | ISO | Psma5 (Mus musculus) | 6480464 | [trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of PSMA5 mRNA | CTD | PMID:18930950 | Psma5 | Rat | tungsten | increases expression | ISO | Psma5 (Mus musculus) | 6480464 | Tungsten results in increased expression of PSMA5 mRNA | CTD | PMID:30912803 | Psma5 | Rat | urethane | decreases expression | ISO | PSMA5 (Homo sapiens) | 6480464 | Urethane results in decreased expression of PSMA5 mRNA | CTD | PMID:28818685 | Psma5 | Rat | valdecoxib | increases expression | EXP | | 6480464 | valdecoxib results in increased expression of PSMA5 mRNA | CTD | PMID:24136188 | Psma5 | Rat | valproic acid | decreases methylation | ISO | PSMA5 (Homo sapiens) | 6480464 | Valproic Acid results in decreased methylation of PSMA5 gene | CTD | PMID:29154799 | Psma5 | Rat | valproic acid | affects expression | ISO | Psma5 (Mus musculus) | 6480464 | Valproic Acid affects the expression of PSMA5 mRNA | CTD | PMID:17292431 | Psma5 | Rat | valproic acid | increases expression | EXP | | 6480464 | Valproic Acid results in increased expression of PSMA5 mRNA | CTD | PMID:21318169 | Psma5 | Rat | valproic acid | affects expression | ISO | PSMA5 (Homo sapiens) | 6480464 | Valproic Acid affects the expression of PSMA5 mRNA | CTD | PMID:25979313 | Psma5 | Rat | valproic acid | increases expression | ISO | PSMA5 (Homo sapiens) | 6480464 | Valproic Acid results in increased expression of PSMA5 mRNA | CTD | PMID:23179753|PMID:27188386|PMID:29154799 | Psma5 | Rat | vorinostat | increases expression | ISO | PSMA5 (Homo sapiens) | 6480464 | vorinostat results in increased expression of PSMA5 mRNA | CTD | PMID:27188386 | |






















